在患有DYNC1H1相关的患者中,对性饮食治疗有好反应

相关实验视频

Updated: Jun 1, 2025

09:06

A Low-cost Method for Analyzing Seizure-like Activity and Movement in Drosophila

Published on: February 19, 2014

13.5K

Chalongchai Phitsanuwong^1,2, Stephanie Schimpf^1,2, Sho T Yano¹

¹Section of Pediatric Neurology, Department of Pediatrics, The University of Chicago, Chicago, IL, United States.

Epilepsy & behavior reports

|January 21, 2025

概括

丁氨酸细胞质1重链1 (DYNC1H1) 基因变异导致各种疾病,包括耐药性. 性饮食 (KD) 在患有DYNC1H1相关的儿童中实现了无发作,显示了其潜在的疗效.

科学领域:

遗传学是一个遗传学.
神经学神经学
代谢障碍代谢障碍代谢障碍

背景情况:

与DYNC1H1相关的疾病包括一系列疾病,包括神经发育,大脑形和神经肌肉疾病.
是一种常见的特征,通常呈现为耐药性发育性脑病变,如婴儿发作综合征 (IESS).
目前用于DYNC1H1相关的治疗方法缺乏特定的疗效,需要探索替代治疗策略.

研究的目的:

报告一个患有DYNC1H1致病变体的患者成功治疗耐药性的病例.
评估经典饮食 (KD) 作为治疗的单一疗法在这种遗传疾病中的疗效.

主要方法:

一个3岁女孩患有致病性DYNC1H1变异呈现IESS的案例研究.
患者接受了阿德里诺皮质激素 (ACTH),维加巴林和克洛巴赞的治疗,但没有成功.
随后,患者接受了经典的性饮食 (KD) 作为单疗法.

主要成果:

患者在KD上实现了两年多的完全无发作.
在警觉,认知能力和肌肉度方面观察到显著改善.
电脑电图 (EEG) 在基因饮食治疗后正常化.

结论:

经典的性饮食 (KD) 在患有DYNC1H1致病变体的患者中显示出高效的单一疗法.
凯迪代表了管理与DYNC1H1相关疾病相关的耐药性的有前途的治疗选择.
需要进一步的研究来探索KD在DYNC1H1相关的更广泛应用.

关键词:

在DYNC1H1中,你会看到DYNC1H1的字符.饮食疗法是一种饮食疗法.遗传性是一种遗传性.婴儿发作综合征儿童发作综合征基因饮食是基因的饮食.

相关概念视频

01:20

Antiepileptic Drugs: Potassium Channel Activators

142

Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...

142

01:15

Hypoglycemia and Glucagon

150

Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...

150

01:24

Arteries of the Lower Limbs

177

Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...

177

01:20

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein

230

Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...

230

01:17

Antiepileptic Drugs: Calcium Channel Blockers

299

Calcium channel blockers, a class of antiepileptic drugs, regulate the flow of calcium ions within neurons.
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...

299

01:08

Antiepileptic Drugs: Sodium Channel Blockers

379

Antiepileptic drugs are specialized medications that prevent seizures in individuals diagnosed with epilepsy. These drugs primarily function by blocking the movement of sodium ions through channels in the neuronal membrane, inhibiting the repetitive firing of action potentials often associated with seizures.
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...

379